Vacirca Jeff L has filed 7 insider transactions across 2 companies since July 2023.
Most recent transaction: a grant/award of 2492 shares of Caris Life Sciences, Inc. ($CAI) on February 26, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 26, 2026 | Caris Life Sciences, Inc. | $CAI | Vacirca Jeff L | Director | A | Common Stock | 2492 | $20.06 | 18,621.0000 | 297,211,838 | 15.45% | 0.00% |
| June 11, 2024 | Assertio Holdings, Inc. | $ASRT | Vacirca Jeff L | Director | P | Common Stock | 10000 | $1.11 | 151,159.0000 | 71,031,000 | 7.08% | 0.01% |
| May 23, 2024 | Assertio Holdings, Inc. | $ASRT | Vacirca Jeff L | Director | A | Common Stock | 53750 | $0.00 | 141,159.0000 | 71,031,000 | 61.49% | 0.08% |
| May 23, 2024 | Assertio Holdings, Inc. | $ASRT | Vacirca Jeff L | Director | A | Stock Option (right to buy) | 81225 | $0.00 | 81,225.0000 | 71,031,000 | 9999.99% | 0.11% |
| July 31, 2023 | Assertio Holdings, Inc. | $ASRT | Vacirca Jeff L | Director | A | Common Stock | 52642 | $0.00 | 52,642.0000 | 0 | 9999.99% | 0.00% |
| July 31, 2023 | Assertio Holdings, Inc. | $ASRT | Vacirca Jeff L | Director | A | Common Stock | 34767 | $0.00 | 87,409.0000 | 0 | 66.04% | 0.00% |
| July 31, 2023 | Assertio Holdings, Inc. | $ASRT | Vacirca Jeff L | Director | A | Stock Option (right to buy) | 5005 | $0.00 | 5,005.0000 | 0 | 9999.99% | 0.00% |